Amneal (NASDAQ: AMRX) is rapidly becoming one of the most dynamic, purpose-driven pharmaceutical companies delivering more affordable access to essential medicines. Our family delivers for yours through a robust U.S. generics business, a growing branded business and deepening portfolios in injectables, biosimilars and select international markets. We’ve bolstered our world-class scientific rigor, production capabilities and commercial infrastructure. And we invest substantially in our people through leadership development and employee well-being programs – all so we can deliver even more value. We are Amneal and We make healthy possible. Content is for informational purposes only and 3rd party content does not reflect Amneal’s opinions. Amneal has the right to remove comments that violate another’s copyright or intellectual property, mention an Amneal product, use profanity or are defamatory, promote and solicit for third-party sites, initiatives, or products, or are factually inaccurate or misleading or spam. Amneal recommends that you consult with your healthcare provider regarding personal health matters. To report a product complaint or adverse event related to an Amneal product, contact Drug Safety at 877-835-5472, option 3 or drugsafety@amneal.com. If you are currently experiencing a life-threatening event, please immediately contact 911.
View Top Employees from Amneal PharmaceuticalsWebsite | http://www.amneal.com |
Ticker | AMRX |
Revenue | $1.63 billion |
Funding | $250 million |
Employees | 5,196 (3,660 on RocketReach) |
Founded | 2002 |
Address | 400 Crossing Boulevard, Bridgewater, New Jersey 08807, US |
Phone | (908) 409-6822 |
Fax | (908) 947-3146 |
Technologies |
JavaScript,
HTML,
PHP
+124 more
(view full list)
|
Industry | Pharmaceutical Manufacturing, Pharmaceuticals, Healthcare |
Keywords | Affordable, Biosimilars, Injectable Drugs, Branded Pharmaceuticals, Healthcare, Affordable Healthcare, Patient-Centric Healthcare, Pharmaceutical Innovation, Biotechnology |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 325 Companies, NAICS Code 325413 Companies, NAICS Code 32 Companies |
Looking for a particular Amneal Pharmaceuticals employee's phone or email?
The Amneal Pharmaceuticals annual revenue was $1.63 billion in 2024.
Anastasios Konidaris is the CFO of Amneal Pharmaceuticals.
3,660 people are employed at Amneal Pharmaceuticals.
Amneal Pharmaceuticals is based in Bridgewater, New Jersey.
The NAICS codes for Amneal Pharmaceuticals are [3254, 32541, 325, 325413, 32].
The SIC codes for Amneal Pharmaceuticals are [28, 283].